Development and Evaluation of a Pediatric Epilepsy Training Program for First Level Providers in Zambia

Autor: Archana A. Patel MD, MPH, Ornella Ciccone MD, Kafula Lisa Nkole MBBS, MD, Prisca Kalyelye BS, Lauren Sham MD, Agnieszka Kielian MD, Tamar Berger MD, Hanalise V. Huff MD, Hannah F. Johnson, Mercy Sulu BS, Manoj Mathews MBBS, MD, Maitreyi Mazumdar MD, MPH

Publikováno v: Global Pediatric Health, Vol 7 (2020)

Introduction . The developing world continues to face challenges in closing the large treatment gap for epilepsy, due to a high burden of disease and few experienced providers to manage the condition. Children with epilepsy are susceptible to higher

Externí odkaz: https://doaj.org/article/ecb8380b0420451db0299492dc677c6b

May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk?

Autor: Francolini G; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Ciccone LP; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Di Cataldo V; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Detti B; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Simontacchi G; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Loi M; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Mangoni M; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Desideri I; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Meattini I; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy., Livi L; Giulio Francolini, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Lucia Pia Ciccone, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Vanessa Di Cataldo, MD, Cyberknife Center, Istituto Fiorentino di Cura ed Assistenza (IFCA), University of Florence, Florence, Italy; Beatrice Detti, MD, Gabriele Simontacchi, MD, and Mauro Loi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy; Monica Mangoni, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; Isacco Desideri, MD, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy; and Icro Meattini, MD, and Lorenzo Livi, MD, Azienda Ospedaliero Universitaria Careggi, University of Florence, Radiation Oncology Unit, Florence, Italy, Department of Experimental and Clinical Biomedical Sciences 'M. Serio,' University of Florence, Florence, Italy.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Nov 20; Vol. 39 (33), pp. 3762-3763. Date of Electronic Publication: 2021 Sep 17.